Harry Stylli Insider Profile
11 Followers
Harry Stylli, Chairman & CEO, Director, Ten Percent Owner at Biora Therapeutics, holds 14.82M shares in Biora Therapeutics (Ticker: BIORQ), holds 142.51K shares in Sequenom (Ticker: SQNM).
Harry Stylli's Trading History
| BIORQBiora Therapeutics | Aug 17, 2021 | Chairman & CEO, Director, Ten Percent Owner | Uninformative Sell | 17.16K | ― | |
| SQNMSequenom | Mar 16, 2009 | ― | Informative Buy | 26.85K | $340.60K |
You May Also Like
Harry Stylli insider profile FAQ
What is the percentage of profitable transactions made by Harry Stylli?
The percentage of profitable transactions made by Harry Stylli is 0%.
What is the average return per transaction made by Harry Stylli?
The average return per transaction made by Harry Stylli is -63.40%.
What stocks does Harry Stylli hold?
Harry Stylli holds: BIORQ, SQNM stocks.
What was Harry Stylli’s latest transaction?
Harry Stylli’s latest transaction was an Uninformative Sell of $17.16K.
What was Harry Stylli's most profitable transaction?
Harry Stylli’s most profitable transaction was an Informative Buy of BIORQ stock on December 4, 2020. The return on the trade was -27.80%.
What is Harry Stylli's role in Biora Therapeutics?
Harry Stylli's role in Biora Therapeutics is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
